Proactive Investors - Run By Investors For Investors

Milestone Scientific gaining commercial traction with its CompuFlo Epidural System

Milestone Scientific Inc (NYSE:MLSS) Clinical Director Dr. Mark Hochman tells Proactive Investors the New Jersey-based R&D company specializing in developing medical devices is in the first phase of commercializing its FDA-approved CompuFlo Epidural System, which uses its Dynamic Pressure Sensing technology.

Dr. Mark Hochman says over the last few months, positive results of four clinical studies involving CompuFlo have been published across major anesthesia journals, thus leading Milestone to begin engaging in product demos and trials within hospitals and clinics.

 
View full MLSS profile View Profile

Milestone Scientific Inc Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use